Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

Detaylı Bibliyografya
Asıl Yazarlar:	Xu, S, Scott, CAB, Coleman, RL, Tuomilehto, J, Holman, RR
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Wiley 2021

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
Yazar:: Xu, S, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
Yazar:: Wamil, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
Yazar:: Leal, J, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
Yazar:: Califf, R, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
Yazar:: Currie, G, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
Yazar:: Liam Mc Morrow, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Impaired glucose tolerance: who and how treats it?
Yazar:: M. N. Mamedov
Baskı/Yayın Bilgisi: (2005-12-01)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Yazar:: Holman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
Yazar:: Yates, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
Yazar:: Yates, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
Yazar:: Wamil, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
Yazar:: Susanne Andersson, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
Yazar:: Nihar Ranjan Mohanty, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
Yazar:: Wamil, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
Yazar:: Farrer, M, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
Yazar:: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Baskı/Yayın Bilgisi: (2012-01-01)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Yazar:: Preiss, D, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
Yazar:: Califf, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
Yazar:: Holman, R
Baskı/Yayın Bilgisi: (1996)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
Yazar:: Yutaka Inoue, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
Yazar:: Page, R, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
Yazar:: Ursula Mager, ve diğerleri
Baskı/Yayın Bilgisi: (2008-08-01)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
Yazar:: Xin Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
Yazar:: Anke Tönjes, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women.
Yazar:: Huibin Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Yazar:: Gerstein, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
Yazar:: Preiss, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Resting heart rate and impaired glucose regulation in middle-aged and elderly Chinese people: a cross-sectional analysis
Yazar:: Zhen Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2017-09-01)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
Yazar:: Dos Santos, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Impaired glucose tolerance in sleep disorders.
Yazar:: Marietta Keckeis, ve diğerleri
Baskı/Yayın Bilgisi: (2010-03-01)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Metabolic disorders in patients with impaired glucose tolerance, with or without underlying ischaemic heart disease
Yazar:: Brkić Milena, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
Yazar:: Yupu Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
Yazar:: Mostafa, SA, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
Yazar:: Mc Morrow, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease
Yazar:: Lu Yu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial
Yazar:: Marilia Harumi Higuchi dos Santos, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

List of people who have paid
Yazar:: Cork County Association, CCA

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Yazar:: Latini, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
Yazar:: Sharma, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

Benzer Materyaller

Benzer Materyaller